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Disruption of Hemochromatosis Protein and
Transferrin Receptor 2 Causes Iron-Induced
Liver Injury in Mice
Roheeth D. Delima,1,2 Anita C.G. Chua,1,2 Janina E.E. Tirnitz-Parker,1,2,3 Eng K. Gan,1,4 Kevin D. Croft,5
Ross M. Graham,1,2,3 John K. Olynyk,1,2,4,6 and Debbie Trinder1,2
Mutations in hemochromatosis protein (HFE) or transferrin receptor 2 (TFR2) cause he-
reditary hemochromatosis (HH) by impeding production of the liver iron-regulatory hor-
mone, hepcidin (HAMP). This study examined the effects of disruption of Hfe or Tfr2,
either alone or together, on liver iron loading and injury in mouse models of HH. Iron sta-
tus was determined in Hfe knockout (Hfe2/2), Tfr2 Y245X mutant (Tfr2mut), and double-
mutant (Hfe2/23Tfr2mut) mice by measuring plasma and liver iron levels. Plasma alanine
transaminase (ALT) activity, liver histology, and collagen deposition were evaluated to
assess liver injury. Hepatic oxidative stress was assessed by measuring superoxide dismutase
(SOD) activity and F2-isoprostane levels. Gene expression was measured by real-time poly-
merase chain reaction. Hfe2/23Tfr2mut mice had elevated hepatic iron with a periportal
distribution and increased plasma iron, transferrin saturation, and non-transferrin-bound
iron, compared with Hfe2/2, Tfr2mut, and wild-type (WT) mice. Hamp1 expression was
reduced to 40% (Hfe2/2 and Tfr2mut) and 1% (Hfe2/23Tfr2mut) of WT values. Hfe2/2
3Tfr2mut mice had elevated plasma ALT activity and mild hepatic inﬂammation with scat-
tered aggregates of inﬁltrating inﬂammatory cluster of differentiation 45 (CD45)–positive
cells. Increased hepatic hydoxyproline levels as well as Sirius red and Masson’s Trichrome
staining demonstrated advanced portal collagen deposition. Hfe2/2 and Tfr2mut mice had
less hepatic inﬂammation and collagen deposition. Liver F2-isoprostane levels were ele-
vated, and copper/zinc and manganese SOD activities decreased in Hfe2/23Tfr2mut,
Tfr2mut, and Hfe2/2 mice, compared with WTmice. Conclusion: Disruption of both Hfe
and Tfr2 caused more severe hepatic iron overload with more advanced lipid peroxidation,
inﬂammation, and portal ﬁbrosis than was observed with the disruption of either gene
alone. The Hfe2/23Tfr2mut mouse model of iron-induced liver injury reﬂects the liver
injury phenotype observed in human HH. (HEPATOLOGY 2012;56:585-593)
P
rimary and secondary iron overload disorders are
important causes of liver disease and associated
morbidity worldwide.1 The most common pri-
mary iron overload disorder is hereditary hemochro-
matosis (HH), which affects approximately 1 in 200
individuals of Northern European descent.2 There are
four types of HH; the most common, HH type 1, is
caused primarily by homozygosity for the C282Y
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mutation in the hemochromatosis protein (HFE).3
Iron overload disease develops in up to 30% of these
individuals and can result in signiﬁcant hepatic, pan-
creatic, cardiac, or musculoskeletal tissue damage.4 Ju-
venile, or HH type 2, is rare and is caused by muta-
tions in hemojuvelin (HJV) or hepcidin (HAMP).5
HH type 3 is also rare and is caused by mutations in
transferrin receptor 2 (TFR2),6 whereas HH type 4 is
caused by mutations in ferroportin.7 Almost all cases
of HH result in impaired HAMP synthesis. Decreased
HAMP levels in HH cause increased iron absorption
from the duodenum, with the excess iron being depos-
ited mainly in the liver.1,8
Studies have shown that when hepatic iron concen-
tration exceeds 60 lmol/g, hepatic stellate cells
(HSCs) begin to exhibit early signs of activation, an
integral event in the initiation of hepatic ﬁbrosis.9 As
hepatic iron levels increase further, the risk of signiﬁ-
cant liver ﬁbrosis and, ultimately, cirrhosis increases.10
Although the exact mechanisms of liver injury induced
by iron overload have not yet been fully elucidated, it
is thought that the accumulation of excess iron-cata-
lyzed reactive oxygen species (ROS) plays a signiﬁcant
role. Previous studies have demonstrated decreased he-
patic levels of antioxidants, such as superoxide dismu-
tase (SOD), ascorbate, b-carotene, and vitamins E and
A in iron overload conditions.11,12 Furthermore, iron
increases the level of lipid peroxidation (LPO) prod-
ucts, such as malondialdehyde and F2-isoprostanes,
13
which can cause mutagenesis in DNA.14 LPO-induced
DNA lesions are increased 2- to 3-fold in the livers of
HH patients and, together with the iron overload
observed in HH, are associated with an approximately
20-fold increased risk of hepatocellular carcinoma.15,16
Oxidative stress has been shown to activate apoptosis
and necrosis, promoting the synthesis and release of
proinﬂammatory and ﬁbrogenic factors that alter
Kupffer cell and hepatocyte functions, triggering the
activation of HSCs and ﬁbrogenesis.8
There are a number of murine models that recapitu-
late the disturbed iron metabolism of HH.17 The ﬁrst
HH mouse developed was an Hfe knockout (Hfe/)
mouse model of HH type 1.18 Hjv and Hamp knock-
out mouse models effectively reﬂect HH type 2.17
There are several models of HH type 3, including the
Tfr2 Y245X mutant (Tfr2mut) mouse that is ortholo-
gous to the Y250X mutation identiﬁed in some
patients with HH type 3.19 Knockout of ferroportin is
embryonically lethal; however, the ﬂatiron mouse,
which has a missense mutation (H32R) in ferroportin,
exhibits a phenotype similar to that observed in HH
type 4.18 To date, there is no report on the induction
of liver toxicity, injury, or ﬁbrosis in any untreated
genetic mouse models of HH. Tan et al., however,
recently reported early signs of ﬁbrosis in Hfe/ mice
fed a modiﬁed fat diet.20 In the present study, we
describe iron-induced liver injury in Hfe/Tfr2mut
mice, where disruption of both Hfe and Tfr2 causes
more severe iron loading than disruption of either Hfe
or Tfr2 alone, leading to enhanced liver injury and
ﬁbrosis.
Materials and Methods
Animals. Hfe/ mice were generated by the dis-
ruption of the Hfe gene using homologous recombina-
tion, as described by Zhou et al.18 Tfr2mut mice were
generated with a Y245X mutation in Tfr2, as reported
previously.19 Hfe/ and Tfr2mut mice were back-
crossed for 10 generations onto an AKR genetic back-
ground (Animal Resource Center, Murdoch, Western
Australia, Australia). Hfe/ and Tfr2mut mice were
then crossed to generate Hfe/Tfr2mut double-mu-
tant mice. Hfe/, Tfr2mut, Hfe/Tfr2mut, and
wild-type (WT) mice (AKR background) were fed
standard mouse chow (200 mg iron/kg diet; Specialty
Feeds, Glen Forrest, Western Australia, Australia) ad
libitum from 4 weeks of age. An additional group of
WTmice was fed an iron-supplemented diet (20 g car-
bonyl iron/kg diet; Specialty Feeds) for 3 weeks from
8 weeks of age. At 11 weeks of age, after overnight
fasting, blood was collected by cardiac puncture and
organs were perfused in situ with isotonic saline. Livers
were collected and snap-frozen in liquid nitrogen or
ﬁxed in formalin. This study was approved by The
University of Western Australia (Perth, Western Aus-
tralia, Australia) Animal Ethics Committee.
RNA Expression. Total RNA was isolated from liver
tissue using TRI Reagent (Ambion Biosystems, Score-
sby, Victoria, Australia) and reverse-transcribed using
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Superscript III (Invitrogen, Mulgrave, Victoria, Aus-
tralia), as described previously.21 transferrin receptor 1
(Tfr1), Tfr2, Hamp1, b-actin,21 bone morphogenic
protein (Bmp6),22 and inhibitor of differentiation 1
(Id1)23 transcripts were measured by real-time
polymerase chain reaction in a Rotor-Gene 3000
(Qiagen, Doncaster, Victoria, Australia) using primers,
as previously described. Hfe expression was measured
using a forward primer, 5’-CAGCTGAAACGGCTC
CTG-3’, and a reverse primer, 5’-CGAGTCACTTTC
ACCAAAGTAGG-3’. Gene expression was quantiﬁed
using standard curves generated using plasmids con-
taining complementary DNA of the gene of interest
and normalized against b-actin messenger RNA
(mRNA) expression.
Iron Parameters. Plasma iron, transferrin satura-
tion, and non-transferrin-bound iron (NTBI) concen-
tration were measured as previously described.24 He-
patic nonheme iron concentration (HIC) was
measured using bathophenanthroline disulfonic acid
by the method of Kaldor.25
Histology. Liver tissue was ﬁxed in 10% neutral
buffered formalin for 12 hours before being subjected
to routine histological processing and stained with he-
matoxylin and eosin (H&E). Liver sections were
stained with Perls’ Prussian blue for the detection of
tissue iron as well as with Sirius red and Masson’s tri-
chrome for the detection of collagen.26 Stained sec-
tions were digitized using an Aperio Scanscope XT
(Aperio Technologies, Vista, CA) and analyzed using a
positive pixel-count algorithm supplied by the manu-
facturer. Pixel positivity was determined by the num-
ber of pixels representing stained tissue divided by the
total number of pixels in the whole liver section.
Immunoﬂuorescence. Cluster of differentiation 45–
positive (CD45þ) staining was performed on methanol/
acetone (1:1) ﬁxed liver cryosections using a rat anti-
CD45 antibody (Ly-5, 1:150; BD Pharmingen, San
Diego, CA) and detected with goat antirat Alexa Fluor
594 or goat antirat Alexa Fluor 488 (1:200; Invitrogen,
Mulgrave, Victoria, Australia) and mounted with Long
Gold antifade reagent, containing 40,6-diamidino-2-phe-
nylindole (DAPI; Invitrogen), for nuclear quantitation.
Quantiﬁcation was performed by the acquisition of six
random, nonoverlapping ﬁelds of view per tissue sam-
ple, followed by colocalization analysis of CD45 and
DAPI (nuclear quantiﬁcation) using the AnalySIS Life
Science Professional program (Olympus, Melbourne,
Victoria, Australia). Ferritin staining was performed
using a rabbit antiferritin antibody (1:800; Dako,
Glostrup, Denmark) and detected using a goat antirab-
bit Alexa Fluor 594 (1:200; Invitrogen).
Liver Injury. Plasma alanine aminotransferase
(ALT) was measured as an indicator of liver injury
using a kit according to the manufacturer’s instructions
(Sigma-Aldrich, St. Louis, MO). Liver F2-isoprostanes,
a marker of LPO, was measured by gas chromatogra-
phy/mass spectrometry using a deuterium-labeled in-
ternal standard, as previously described.27 The antioxi-
dant, butylated hydroxyl toluene, was added to liver
tissue to scavenge any ROS generated during tissue
storage and processing. Activities of antioxidant
enzymes copper/zinc and manganese SOD were meas-
ured in the liver as an index of oxidative stress using a
kit according to the manufacturer’s instructions (Cay-
man Chemical, Sydney, New South Wales, Australia).
Liver hydroxyproline content was measured as a bio-
chemical marker of liver collagen using a kit according
to the manufacturer’s instructions (QuickZyme Bio-
sciences, Leiden, Netherlands).
Statistical Analysis. Results are expressed as mean
6 standard error of the mean (SEM), where n ¼ 5-15
mice per group. Differences between groups were ana-
lyzed using analysis of variance with Tukey’s multiple
comparison post-test or an unpaired Student’s t test
(GraphPad Prism; GraphPad Software, Inc., La Jolla,
CA). Differences between groups were deﬁned as stat-
istically signiﬁcant for P < 0.05.
Results
Liver Gene Expression. Expression of Hfe, Tfr1,
Tfr2, Bmp6, Id1, and Hamp1 genes is shown in Table 1.
Hfe expression in Tfr2mut and WTmice was similar and
undetectable in Hfe/ and Hfe/Tfr2mut mice (P <
0.001). Tfr2 mRNA expression in Tfr2mut and Hfe/
Tfr2mut mice was decreased by approximately 65%,
compared with non-iron-loaded WTmice (P < 0.001).
Tfr2 mRNA expression in Hfe/ and iron-loaded WT
mice was also lower than non-iron-loaded WTmice (P
< 0.05). Tfr1 mRNA expression was reduced in all
types of HH mice and iron-loaded WTmice, compared
with non-loaded WT mice (P < 0.05), consistent with
liver iron loading. Expression of the gene encoding the
iron-regulatory hormone, Hamp1, was decreased to
approximately 40% in Hfe/ and Tfr2mut mice, com-
pared with non-iron-loaded WT mice. In Hfe/
Tfr2mut mice, Hamp1 expression was almost abolished,
being further reduced to approximately 1% or 3% of
that observed in non-iron-loaded WTmice (P < 0.01)
or Hfe/ and Tfr2mut mice (P < 0.05), respectively.
Hamp1 expression, as expected, was increased in iron-
loaded WT mice, compared with non-iron-loaded WT
mice (P < 0.05) and HH mice (P < 0.001). Bmp6
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expression was increased in all HH and iron-loaded WT
mice (p < 0.05), compared with non-iron-loaded WT
mice, consistent with iron-dependent regulation of
Bmp6. However, phosphorylated mothers against decap-
entaplegic (Smad)1/5/8 protein levels were decreased
signiﬁcantly in Hfe/Tfr2mut mice, compared with
all other types of mice (P < 0.05), and inhibited in
Hfe/ and Tfr2mut mice, compared with iron-loaded
WT mice (P < 0.05; Supporting Fig. 1). Id1 (Bmp6/
pSmad1/5/8 target), as with Hamp1 expression, was
decreased in all HH mice, compared with non-iron-
loaded WT mice (P < 0.05). This is consistent with
impaired pSmad1/5/8 signaling in HH mice.
Plasma Iron Parameters. Plasma iron concentration
and transferrin saturation were higher in Hfe/
Tfr2mut, Tfr2mut, Hfe/, and iron-loaded WT mice,
compared with non-iron-loaded WT mice (P < 0.05;
Fig. 1A,B). Iron concentration and transferrin saturation
were greatest in Hfe/Tfr2mut mice (P < 0.05; Fig.
1A,B). Plasma iron concentration in Tfr2mut mice was
increased, compared to Hfe/ mice (P < 0.05). Plasma
NTBI concentration was also elevated in all iron-loaded
mice (P < 0.05). In Hfe/Tfr2mut mice, NTBI levels
were 7-fold higher than non-iron-loaded WT mice and
more than 2-fold higher than Hfe/, Tfr2mut, and iron-
loaded WTmice (P < 0.001; Fig. 1C).
HIC. HIC was elevated in all iron-loaded mice,
compared with non-iron-loaded mice. HIC in Hfe/,
Tfr2mut, and iron-loaded WT mice was similar and
approximately 3-fold higher than non-loaded WT
mice (P < 0.001; Fig. 2A). HIC was greater in Hfe/
Tfr2mut mice, compared with either Hfe/ or Tfr2mut
mice (P < 0.01; Fig. 2A) and approximately 5-fold that
of the non-iron-loaded WT mice. Perls’ Prussian blue
staining of liver sections from Hfe/Tfr2mut mice
demonstrated a periportal distribution of iron, similar
to that observed in Hfe/, Tfr2mut, and iron-loaded
WT mice. However, the intensity of iron staining was
greater in Hfe/Tfr2mut than in the other types of
mice (Fig. 2B-D). These results indicate an increased
iron burden in Hfe/Tfr2mut mice.
Liver Injury. H&E-stained liver sections from
Hfe/Tfr2mut mice demonstrated mild inﬂamma-
tion with evidence of scattered foci of inﬁltrating
inﬂammatory cells throughout the liver parenchyma
(Fig. 3). Immunoﬂuorescent detection of the pan leu-
kocyte marker, CD45, revealed that the cell aggregates
consisted mainly of CD45þ inﬂammatory cells (Fig.
3A,E) that colocalized predominately, but not exclu-
sively, with the iron storage protein, ferritin, in peri-
portal regions of the liver (Supporting Fig. 2). The
number of CD45þ inﬂammatory cells was signiﬁcantly
Table 1. mRNA Expression of Iron Genes
Gene WT WTþFe Hfe/ Tfr2mut Hfe/Tfr2mut
Hfe 33 6 2 29 6 1 —*,† 34 6 1‡ —*,†,§
Tfr2 85 6 5 65 6 5* 62 6 10* 30 6 4*,†,‡ 28 6 6*,†,‡
Tfr1 98 6 17 59 6 5* 35 6 9*,† 43 6 6*,† 43 6 8*,†
Hamp1 73 6 14 120 6 12* 34 6 13*,† 29 6 8*,† 0.9 6 0.4*,†,‡,§
Bmp6 1.8 6 0.2 5.2 6 0.3* 3.3 6 0.0*,† 3.1 6 0.3*,† 3.7 6 0.4*,†
Id1 91 6 3 487 6 34* 42 6 3*,† 62 6 12*,† 52 6 6*,†
Results are expressed as mean 6 SEM (n ¼ 5-15) mRNA copy number of the gene of interest relative to b-actin.
*P < 0.05 versus WT.
†P < 0.05 versus WTþFe.
‡P < 0.05 versus Hfe/.
§P < 0.05 versus Tfr2mut denote signiﬁcance between groups.
Fig. 1. Plasma iron parameters. Plasma iron concentration (A), transferrin saturation (B), and NTBI concentration (C) were measured in WT,
iron-loaded WT (WTþFe), Hfe/, Tfr2mut, and Hfe/Tfr2mut mice. Results are expressed as mean 6 SEM (n ¼ 5-15). a, P < 0.05 versus
WT; b, P < 0.05 versus WTþFe; c, P < 0.05 versus Hfe/; d, P < 0.05 versus Tfr2mut.
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increased in the livers from Hfe/Tfr2mut mice,
compared with the other groups of mice (P < 0.05),
whereas the number of CD45þ cells in Hfe/,
Tfr2mut, and iron-loaded WT mice was not signiﬁ-
cantly different from those in non-iron-loaded WT
mice (Fig. 3F). Another unique feature of Hfe/
Tfr2mut mice was the evidence of inﬂammatory side-
ronecrosis of hepatocytes, which was not observed in
any other group of mice (Fig. 3E).
Liver injury was assessed by examining plasma ALT
as well as hepatic SOD and F2-isoprostane levels.
Plasma ALT activity was increased in Hfe/Tfr2mut
mice by at least 1.8-fold, compared with all other
types of mice (P < 0.001; Fig. 4A). Both hepatic cop-
per/zinc (cytosolic) and manganese (mitochondrial)
SOD activities were signiﬁcantly decreased in all HH
mice. In Hfe/Tfr2mut mice copper/zinc SOD levels
were similar, whereas manganese SOD levels were sig-
niﬁcantly lower than Hfe/ and Tfr2mut mice (P <
0.01; Fig. 4B). Liver F2-isoprostanes were elevated in
all groups of HH mice, compared with non-iron-
loaded WT mice (P < 0.01), with Hfe/ Tfr2mut
mice having similar liver F2-isoprostane levels to iron-
loaded WTmice and signiﬁcantly higher levels than ei-
ther Hfe/ or Tfr2mut mice (P < 0.01; Fig. 4C).
Collagen Deposition. Hepatic collagen deposition, a
marker of ﬁbrosis, was examined by histology using Sir-
ius red and Masson’s trichrome staining and by bio-
chemical measurement of hydroxyproline levels.
Hydroxyproline levels were increased in all iron-loaded
mice. In Hfe/Tfr2mut mice, hydroxyproline levels
were signiﬁcantly increased, compared with Tfr2mut
mice, and both were elevated, compared with Hfe/
and iron-loaded WT mice (Fig. 4D; P < 0.05). Like-
wise, Hfe/Tfr2mut mice had signiﬁcantly increased
Sirius red staining, compared with Hfe/, Tfr2mut, and
iron-loaded WT mice (P < 0.05), which, in turn,
exhibited greater collagen deposition than non-iron-
loaded WT mice (P < 0.01; Fig. 5A-F). Sirius red
staining revealed portal tract thickening and periportal
ﬁbrosis in Hfe/Tfr2mut mice. In addition, there was
evidence of portal tract bridging in Hfe/ Tfr2mut
mice, which was not evident in other groups. Quantiﬁ-
cation of Sirius red staining correlated with HIC (r2 ¼
0.98; P ¼ 0.001), plasma NTBI (r2 ¼ 0.82; P ¼
0.033), as well as hydroxyproline (r2 ¼ 0.89; P ¼
0.015) and F2-isoprotane levels (r
2 ¼ 0.77; P ¼ 0.048)
in HH mice. This suggests that the collagen levels
measured by biochemical assay were consistent with his-
tological observations using Sirius red staining and were
dependent on both plasma NTBI and HIC in HH
mice. Furthermore, the intensity of trichrome staining,
a commonly used, but less sensitive, marker of ﬁbrosis,
was also signiﬁcantly enhanced in Hfe/Tfr2mut and
Tfr2mut mice (Fig. 6F), with evidence of collagen thick-
ening in the periportal region of the liver (Fig. 6A-E).
Discussion
In this study, we have used Hfe/ and Tfr2mut
mouse models of HH types 1 and 3, respectively, and
a Hfe/Tfr2mut mouse model to examine the effects
of disruption of Hfe and Tfr2, either alone or in com-
bination, on liver iron loading and iron-induced liver
injury. We describe, to our knowledge, the ﬁrst report
of a genetic HH mouse model of iron-induced liver
injury, the Hfe/Tfr2mut mouse, which reﬂects both
the iron-loaded phenotype and increased liver injury
observed in HH patients.
Hfe/Tfr2mut mice had elevated plasma and he-
patic iron levels, determined by both biochemical and
histological methods, compared with Hfe/ and
Tfr2mut mice. Hamp1 levels were reduced in Hfe/
and Tfr2mut mice and almost abolished in Hfe/
Tfr2mut mice. Hepcidin, the peptide encoded by
Hamp1, is a negative regulator of iron absorption and
Fig. 2. Hepatic iron concentration. Hepatic iron concentration was
determined biochemically and by Perls’ Prussian blue staining. (A)
Results are expressed as mean 6 SEM (n ¼ 5-15). a, P < 0.001
versus WT; b, P < 0.001 versus WTþFe; c, P < 0.01 versus Hfe/;
d, P < 0.001 versus Tfr2mut. Staining was conducted on WT (B), iron-
loaded WT (WTþFe; C), Hfe/ (D), Tfr2mut (E), and Hfe/Tfr2mut
(F) mice. Each panel is representative of staining from 6-8 animals.
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reduced hepcidin levels in Hfe/, Tfr2mut, and Hfe/
Tfr2mut mice would lead to increased iron absorption
and hepatic iron deposition.8 In association with
increased liver iron loading, there was a pronounced
elevation of plasma ALT activity, a marker of liver
injury, in Hfe/Tfr2mut mice. There was also mild
hepatic inﬂammatory cell inﬁltration with scattered foci
of CD45þ leukocytes and some evidence of hepatocyte
sideronecrosis in Hfe/Tfr2mut mice. Elevated
hydroxyproline levels as well as Sirius red and tri-
chrome staining showing marked portal tract collagen
deposition and portal bridging in Hfe/Tfr2mut
mice clearly demonstrates the presence of liver ﬁbrosis
in areas of greatest iron accumulation. In comparison,
Hfe/ and Tfr2mut mice had less collagen deposition
and inﬂammation. Histological evidence of a more pro-
nounced liver damage in Hfe/Tfr2mut mice was
corroborated by decreased SOD activity and enhanced
LPO in the liver, indicating elevated hepatic oxidative
stress.
The iron-dependent regulation of HAMP is con-
trolled by HFE and TFR2, as well as BMP6/SMAD
cell-signaling pathways.22,23,28 It has been demon-
strated that HFE can interact with TFR1 and TFR2
to form a complex that is hypothesized to sense plasma
transferrin saturation and modulate hepcidin synthesis
accordingly.1,8 However, the nature of this mechanism
is yet to be fully elucidated. Our ﬁndings support pre-
vious studies that suggest there is cross-talk between
HFE/TFR2- and BMP6/SMAD-signaling pathways,
because the absence of functional HFE and/or TFR2
attenuated iron-induced phosphorylation of SMAD1/
5/8 and hepcidin expression.23,28
Mice with deletions in both Hfe and Tfr2 have been
generated on other genetic backgrounds.23,28 These
mice, as with our HH murine model, exhibited
Fig. 3. Liver histology. H&E
staining of liver sections from WT
(left panel, A), iron-loaded WT
(WTþFe; B), Hfe/ (C), Tfr2mut
(D), and Hfe/Tfr2mut (left
panel, E) mice. Arrows indicate
inﬂammatory sideronecrosis of he-
patocytes (left panel, E). CD45-
stained (red) liver sections from WT
(right panel, A) and Hfe/
Tfr2mut (right panel, E) mice.
Each panel shows a representative
photomicrograph of staining from 6
animals. The number of CD45þ
cells (F) is expressed as mean 6
SEM (n ¼ 6). a, P < 0.05 versus
WT; b, P < 0.05 versus WTþFe; c,
P < 0.05 versus Hfe/; d, P <
0.05 versus Tfr2mut.
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elevated plasma and liver iron levels, compared with
mice with the appropriate deletion of Hfe or Tfr2, as
well as a marked reduction in Hamp1 expression, con-
sistent with increased liver iron accumulation. How-
ever, the degree of regulation of Hamp1 observed in
Hfe/ and Tfr2mut mice, and its near abrogation
induced by the disruption of both Hfe and Tfr2, sug-
gests that the formation of a Hfe and Tfr2 complex is
not a prerequisite for the initiation of iron-dependent
HAMP synthesis. The degree of iron overload, how-
ever, varies between strains, which is consistent with
previous observations that iron metabolism is modiﬁed
by genetic background.29 Our HH mice were gener-
ated on an AKR background and have relatively high
plasma and liver iron levels, compared with other
strains of mice. Colocalization of a more marked
ﬁbrotic process in areas of greatest iron deposition in
the hepatic periportal regions in our Hfe/Tfr2mut
mice provides further evidence of the importance of
genetic background and phenotypic expression of iron
overload in the pathogenesis of liver injury in HH.
Rodents are generally relatively resistant to iron-
induced liver injury. Dietary carbonyl iron loading of
rats for 3 months produced iron loading in hepato-
cytes, similar to the levels observed in the Hfe/
Tfr2mut mice in the present study, but demonstrated
only early signs of liver injury, including increased
LPO and collagen gene expression. Long-term iron
loading was required for up to 12 months before mor-
phological evidence of ﬁbrosis was observed.30,31 Die-
tary iron supplementation in combination with hepa-
totoxins, such as ethanol and carbon tetrachloride, was
Fig. 4. Biochemical markers of liver injury.
Plasma ALT (A), liver copper/zinc (open bars)
and manganese (hatched bars) SOD (B), liver
F2-isoprotane (C), and hydroxyproline (D) lev-
els were measured in WT, iron-loaded WT
(WTþFe), Hfe/, Tfr2mut, and Hfe/
Tfr2mut mice. Results are expressed as
mean 6 SEM (n ¼ 5-15). a, P < 0.05 ver-
sus WT; b, P < 0.05 versus WTþFe; c, P <
0.05 versus Hfe/; d, P < 0.05 versus
Tfr2mut. For manganese SOD: 1, P < 0.05
versus WT; 2, P < 0.01 versus WTþFe; 3, P
< 0.01 versus Hfe/; 4, P < 0.01 versus
Tfr2mut.
Fig. 5. Collagen deposition in the liver. Sirius red staining of liver
sections from WT (A), iron-loaded WT (WTþFe; B), Hfe/ (C), Tfr2mut
(D), and Hfe/Tfr2mut (E) mice. Staining intensity is quantiﬁed in
(F). There was increased collagen deposition in the portal tracts of
WTþFe, Hfe/, and Tfr2mut mice with advanced thickening of the
portal tract in Hfe/Tfr2mut mice. Results are expressed as mean
6 SEM (n ¼ 6). a, P < 0.01 versus WT; b, P < 0.05 versus WTþFe;
c, P < 0.01 versus Hfe/; d, P < 0.05 versus Tfr2mut. Each panel
is a representative photomicrograph of staining from 6 animals.
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required to accelerate liver injury.32,33 In the present
study, the degree of liver ﬁbrosis observed in Hfe/
Tfr2mut mice at 3 months of age was similar to that
observed after dietary loading of rodents for 12
months.30,31 In our Hfe/Tfr2mut mice, hepatic
inﬂammation, ﬁbrosis, and LPO occurred in the pres-
ence of marked elevation of both plasma NTBI and
hepatic iron levels, similar to those observed in human
HFE-related HH.34,35 Furthermore, the degree of
ﬁbrosis observed in the HH mice was dependent on
both HIC and NTBI levels.
The observation that Hfe/Tfr2mut mice have
increased plasma ALT levels is consistent with previ-
ous observations in HH patients, where the majority
of patients had mildly elevated ALT levels.36 Levels of
the antioxidant enzymes, cytosolic copper/zinc and
mitochondrial manganese SOD, were both decreased
in Hfe/Tfr2mut mice consistent with increased
oxidative stress. Earlier studies have also reported
decreased copper/zinc SOD in dietary iron-over-
loaded animals, whereas manganese SOD was
decreased in Hfe knockout and increased in iron-
loaded rodents.11,20,37 Furthermore, LPO was
increased in HH mice. Unexpectedly, the level of F2-
isoprostanes in dietary iron-loaded mice was greater
than in HH mice with similar HIC. This may be the
result of differences between dietary iron (i.e., high
HAMP) and genetic HH (i.e., low HAMP) models
of liver iron overload where variation in cellular iron
distribution between parenchymal and Kupffer cells
occurs, despite similar total HIC.
Mild liver inﬂammation was observed only in Hfe/
Tfr2mut mice, suggesting that there was an iron-con-
centration threshold effect. Mild inﬂammation has been
documented in human HH studies during the develop-
ment of ﬁbrosis and cirrhosis.38 Deugnier et al. reported
inﬂammatory inﬁltrates in approximately 50% of liver
biopsies from HH patients.39 Inﬂammation was pre-
dominantly present in portal and periportal regions and
correlated with histological iron scores, sideronecrotic
changes in hepatocytes, and hepatic ﬁbrosis. Another
study showed that approximately 25% of liver biopsies
from untreated HH patients displayed moderate inﬂam-
matory inﬁltration.40 Bridle et al. also reported that
60% of liver biopsies from HH patients showed mild
inﬂammation consisting of scattered inﬂammatory foci.
Furthermore, patients with hepatic inﬂammation had a
higher incidence of hepatic ﬁbrosis.41 Iron-loaded and
apoptotic/necrotic hepatocytes are purported to induce
the activation of HSCs by various signaling mecha-
nisms, resulting in enhanced production of proinﬂam-
matory and -ﬁbrogenic cytokines as well as the recruit-
ment of inﬂammatory cells.8 Our study provides further
support for the direct hepatotoxic effects of iron over-
load, which results from the disruption of Hfe and
Tfr2, manifesting as inﬂammation and increased colla-
gen deposition, suggesting the activation of HSCs.
Iron plays an important part in the progression of
hepatic injury, and it does this through its ability to
catalyze the formation of highly reactive, damaging
ROS. ROS induce tissue injury by promoting LPO as
well as protein and DNA modiﬁcation, leading, ulti-
mately, to apoptosis and necrosis. Further investigation
into the molecular mechanisms of iron toxicity and
how it causes liver injury will provide a better under-
standing of the role iron plays in the progression of
liver disease. The Hfe/Tfr2mut mouse represents a
model of the genetic iron overload disorder, HH, that
mimics both iron overload and consequent liver injury
observed in humans with HH.
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